Parametric Portfolio Associates’s Vanda Pharmaceuticals VNDA Stock Holding History

Parametric Portfolio Associates’s Portfolio VNDA Stock Details VNDA Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.36M	Sell	209,062 -78,329	-27%	-$886K	﹤0.01%	2332
2021 Q4	$4.51M	Buy	287,391 +25,937	+10%	+$407K	﹤0.01%	1940
2021 Q3	$4.48M	Sell	261,454 -4,737	-2%	-$81.2K	﹤0.01%	1907
2021 Q2	$5.73M	Buy	266,191 +10,744	+4%	+$231K	﹤0.01%	1761
2021 Q1	$3.84M	Buy	255,447 +75,838	+42%	+$1.14M	﹤0.01%	2345
2020 Q4	$2.36M	Buy	179,609 +88,723	+98%	+$1.17M	﹤0.01%	2555
2020 Q3	$878K	Sell	90,886 -7,592	-8%	-$73.3K	﹤0.01%	2999
2020 Q2	$1.13M	Buy	98,478 +32,477	+49%	+$372K	﹤0.01%	2854
2020 Q1	$684K	Sell	66,001 -105,666	-62%	-$1.1M	﹤0.01%	2994
2019 Q4	$2.82M	Buy	171,667 +49,676	+41%	+$815K	﹤0.01%	2461
2019 Q3	$1.62M	Buy	121,991 +33,077	+37%	+$439K	﹤0.01%	2772
2019 Q2	$1.25M	Buy	88,914 +28,135	+46%	+$396K	﹤0.01%	2938
2019 Q1	$1.12M	Sell	60,779 -62,942	-51%	-$1.16M	﹤0.01%	2973
2018 Q4	$3.23M	Buy	123,721 +101,431	+455%	+$2.65M	﹤0.01%	2236
2018 Q3	$512K	Buy	22,290 +4,671	+27%	+$107K	﹤0.01%	3405
2018 Q2	$336K	Buy	+17,619	New	+$336K	﹤0.01%	3512
2018 Q1	–	Sell	-36,241	Closed	-$551K	–	3967
2017 Q4	$551K	Sell	36,241 -29,335	-45%	-$446K	﹤0.01%	3277
2017 Q3	$1.17M	Buy	65,576 +28,657	+78%	+$513K	﹤0.01%	2938
2017 Q2	$602K	Buy	36,919 +12,769	+53%	+$208K	﹤0.01%	3250
2017 Q1	$338K	Sell	24,150 -1,500	-6%	-$21K	﹤0.01%	3382
2016 Q4	$409K	Buy	+25,650	New	+$409K	﹤0.01%	3287
2015 Q1	–	Sell	-19,932	Closed	-$285K	–	4006
2014 Q4	$285K	Sell	19,932 -815	-4%	-$11.7K	﹤0.01%	3597
2014 Q3	$215K	Sell	20,747 -5,449	-21%	-$56.5K	﹤0.01%	3591
2014 Q2	$424K	Buy	26,196 +328	+1%	+$5.31K	﹤0.01%	3302
2014 Q1	$420K	Buy	25,868 +7,149	+38%	+$116K	﹤0.01%	3266
2013 Q4	$232K	Buy	18,719 +4,789	+34%	+$59.4K	﹤0.01%	3549
2013 Q3	$153K	Buy	13,930 +249	+2%	+$2.74K	﹤0.01%	3663
2013 Q2	$111K	Buy	+13,681	New	+$111K	﹤0.01%	3586